CD28 and neoplasm: Moreover, we found tumor-cell loss of MLL3 or MLL4 promotes survival, proliferation, and cytotoxicity of antigen-nonspecific CD8+ T cells pre-activated by anti-CD3/CD28 antibodies as well (Supplementary Fig. 1o–q).